Association between CBR1 polymorphisms and NSCLC in the Chinese population

  • Authors:
    • Yong Guo
    • Yingying Shen
    • Yongming Xia
    • Jianzhong Gu
  • View Affiliations

  • Published online on: September 14, 2017     https://doi.org/10.3892/ol.2017.6926
  • Pages: 6291-6297
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Carbonyl reductase 1 (CBR1) is theorized to participate in various cellular processes, such as signal transduction, apoptosis, carcinogenesis and drug resistance, and is highly expressed in certain malignancies, including lung tumors. Several studies have provided evidence that gene polymorphisms may affect susceptibility to non‑small cell lung cancer (NSCLC). The present study aimed to investigate the association between the CBR1 single‑nucleotide polymorphisms (SNPs) rs3787728 and rs2835267, and NSCLC in a Chinese population. The data indicated that the allele frequency in CBR1 rs3787728 was significantly different between patients with NSCLC and the controls [odds ratio (OR)=1.209; 95% confidence interval (CI)=1.013‑1.442; P=0.0349], and was significantly different between male patients with NSCLC and the corresponding controls (OR=1.278; 95% CI=1.016‑1.607; P=0.0358). The CBR1 rs3787728 thymine (T)/T allele homozygote was associated with an increased risk of NSCLC in all patients (OR=1.382; 95% CI=1.019‑1.875; P=0.037), and patients possessing the rs3787728 T/T major allele homozygote exhibited a 1.537‑fold greater risk with respect to developing lung squamous‑cell carcinoma (SCC) in all patients (95% CI=1.019‑2.318; P=0.0395). The CBR1 rs3787728 cytosine (C)/C allele homozygote was associated with a decreased risk of adenocarcinoma (ADC) in male patients (OR=0.633; 95% CI=0.413‑0.969; P=0.0348); however, no significant association was observed in CBR1 rs2835267 between SNPs and SCC or ADC‑type NSCLC. In conclusion, the results revealed that genetic polymorphisms of CBR1 rs3787728 were associated with susceptibility to NSCLC. Additional studies are required to identify the functional impact of CBR1 expression and activity in NSCLC.
View References

Related Articles

Journal Cover

November-2017
Volume 14 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Guo Y, Shen Y, Xia Y and Gu J: Association between CBR1 polymorphisms and NSCLC in the Chinese population. Oncol Lett 14: 6291-6297, 2017.
APA
Guo, Y., Shen, Y., Xia, Y., & Gu, J. (2017). Association between CBR1 polymorphisms and NSCLC in the Chinese population. Oncology Letters, 14, 6291-6297. https://doi.org/10.3892/ol.2017.6926
MLA
Guo, Y., Shen, Y., Xia, Y., Gu, J."Association between CBR1 polymorphisms and NSCLC in the Chinese population". Oncology Letters 14.5 (2017): 6291-6297.
Chicago
Guo, Y., Shen, Y., Xia, Y., Gu, J."Association between CBR1 polymorphisms and NSCLC in the Chinese population". Oncology Letters 14, no. 5 (2017): 6291-6297. https://doi.org/10.3892/ol.2017.6926